JUN and non-small cell lung carcinoma: However, nuclear YAP or phospho-c-Jun are 2-fold higher in BM (YAP: 53.3 ± 8.6, phospho-c-Jun: 38.0 ± 9.7) than in primary tumor of patients with metastatic NSCLC.